Bartlett, M.J.; Mabrouk, O.S.; Szabò, L.; Flores, A.J.; Parent, K.L.; Bidlack, J.M.; Heien, M.L.; Kennedy, R.T.; Polt, R.; Sherman, S.J.;
et al. The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia. Int. J. Mol. Sci. 2021, 22, 20.
https://doi.org/10.3390/ijms22010020
AMA Style
Bartlett MJ, Mabrouk OS, Szabò L, Flores AJ, Parent KL, Bidlack JM, Heien ML, Kennedy RT, Polt R, Sherman SJ,
et al. The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia. International Journal of Molecular Sciences. 2021; 22(1):20.
https://doi.org/10.3390/ijms22010020
Chicago/Turabian Style
Bartlett, Mitchell J., Omar S. Mabrouk, Lajos Szabò, Andrew J. Flores, Kate L. Parent, Jean M. Bidlack, Michael L. Heien, Robert T. Kennedy, Robin Polt, Scott J. Sherman,
and et al. 2021. "The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia" International Journal of Molecular Sciences 22, no. 1: 20.
https://doi.org/10.3390/ijms22010020
APA Style
Bartlett, M. J., Mabrouk, O. S., Szabò, L., Flores, A. J., Parent, K. L., Bidlack, J. M., Heien, M. L., Kennedy, R. T., Polt, R., Sherman, S. J., & Falk, T.
(2021). The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia. International Journal of Molecular Sciences, 22(1), 20.
https://doi.org/10.3390/ijms22010020
